Doctor profile · Federal record

Dr. Lauren Strazzula, M.D.

Dermatology Physician (CMS: Dermatology) · Internal Medicine Physician · Plymouth, MA

  • NPI 1598178923
  • Accepts Medicare
  • 12 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1 Scobee Cir Ste 3
Plymouth, MA 023604887
(508) 747-0711
fax (508) 746-9265
Additional location
75 Washington St Ste 200
Norwell, MA 020611795
(781) 878-6495
fax (781) 878-6524

Credentials & registration

NPPES · NUCC
NPI registered
June 2014 — 12 yrs on file
Profile last updated
November 9, 2018
Year of graduation
2014 — 12 yrs since
Specialty taxonomy
207N00000X — NUCC code
State licenses (2)
Massachusetts #273788 · Massachusetts #259978

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1598178923. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
8,408
Distinct HCPCS
10
Medicare allowed
$234,244
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 5,400 25 $2
17003 Destruction of precancer skin growth, 2-14 growths 1,082 219 $8
99213 Established patient office or other outpatient visit, 20-29 minutes 451 336 $99
17000 Destruction of precancer skin growth, 1 growth 350 294 $64
11102 Biopsy of related skin growth, first growth 234 208 $113
99214 Established patient office or other outpatient visit, 30-39 minutes 214 157 $140
99203 New patient office or other outpatient visit, 30-44 minutes 212 212 $123
99204 New patient office or other outpatient visit, 45-59 minutes 100 100 $179
11103 Biopsy of related skin growth, each additional growth 82 64 $58
17110 Destruction of skin growth, 1-14 growths 76 63 $132

In context: peer comparison

Among 4 peers in Plymouth Dermatology Physician, average services per provider: 394. This provider delivers 21× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,490
Transactions
97
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 21 $549.03
Leo Pharma INC. 12 $326.03
Incyte Corporation 12 $293.85
Lilly USA, LLC 7 $231.68
E.R. Squibb & Sons, L.L.C. 12 $186.09
Genzyme Corporation 4 $146.97
Regeneron Healthcare Solutions, INC. 6 $138.32
Amgen INC. 4 $121.14
Dermavant Sciences, INC. 6 $113.01
Ucb, INC. 1 $88.90
Sun Pharmaceutical Industries INC. 5 $77.69
Janssen Biotech, INC. 3 $75.30
Boehringer Ingelheim Pharmaceuticals, INC. 2 $60.98
Merz North America, INC. 1 $27.18
Galderma Laboratories, L.P. 1 $21.46

By nature of payment

Food and Beverage
$2,490

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
505
Patients
334
Total drug cost
$18,013
Drug Type Claims Patients Total cost
Triamcinolone Acetonide Generic 117 81 $1,867
Ketoconazole Generic 90 51 $2,133
Fluorouracil Generic 67 62 $4,412
Hydrocortisone Generic 56 45 $411
Doxycycline Hyclate Generic 41 16 $1,614
Betamethasone Dipropionate Generic 35 25 $3,189
Fluocinonide Generic 29 23 $1,667
Clindamycin Phosphate Generic 28 17 $1,457
Mupirocin Generic 16 14 $144
Valacyclovir (Valacyclovir Hcl) Brand 14 0 $170

Frequently asked questions

Auto-generated from federal data
What is Dr. Lauren Strazzula's medical specialty?
Dr. Lauren Strazzula practices Dermatology Physician in Plymouth, MA.
Where does Dr. Lauren Strazzula practice?
Dr. Lauren Strazzula practices at 1 Scobee Cir Ste 3, Plymouth, MA 023604887. Office phone: 5087470711.
What is Dr. Lauren Strazzula's NPI?
Dr. Lauren Strazzula's National Provider Identifier (NPI) is 1598178923, issued by NPPES.
Does Dr. Lauren Strazzula accept Medicare assignment?
Yes. Dr. Lauren Strazzula accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lauren Strazzula commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.